Literature DB >> 24911984

Hypertrabeculation vs left ventricular noncompaction on echocardiogram: a reason to restrict athletic participation?

David C Peritz1, Aaron Vaughn2, Mario Ciocca3, Eugene H Chung4.   

Abstract

IMPORTANCE: Left ventricular noncompaction (LVNC) is a rare cause of progressive cardiomyopathy thought to result from incomplete myocardial development. It has been associated with an increased risk of sudden death, especially in those with a depressed left ventricular ejection fraction. Thus, the current recommendation for patients with this diagnosis is restriction from participation in competitive sports. OBSERVATIONS: An asymptomatic 18-year-old African American collegiate football player had a murmur on his preparticipation physical examination. Subsequent cardiology workup revealed hypertrabeculation vs LVNC. Second and third opinions were sought from national experts in the field: one gave the diagnosis of LVNC and recommended restriction; the other gave the diagnosis of hypertrabeculation. After a family meeting including the player, mother, team physician, and consulting cardiologist, the player was permitted to participate in football. CONCLUSIONS AND RELEVANCE: Distinguishing between pathologic LVNC and physiologic hypertrabeculation is a diagnostic challenge and is becoming increasingly commonplace with enhanced echocardiography and magnetic resonance imaging modalities. Given the limited data on such patients, careful workup and discussion between patient and providers is required.

Entities:  

Mesh:

Year:  2014        PMID: 24911984     DOI: 10.1001/jamainternmed.2014.1066

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN: 2168-6106            Impact factor:   21.873


  3 in total

1.  Left ventricular hypertrabeculation: a clinical enigma.

Authors:  Nelli Ivanova; Hoda Ahmed; Wael Abuzeid
Journal:  BMJ Case Rep       Date:  2016-11-15

2.  Left Ventricle Non-Compaction Cardiomyopathy Admitted With Multiorgan Failure: A Case Report.

Authors:  Luis F Álvarez Pérez; Jorge E Sandelis Pérez; Juan Nieves-Rivera; Hilton Franqui
Journal:  Cureus       Date:  2020-06-23

3.  Athlete's heart and other entities to consider around.

Authors:  María Martín; Antonio Adeba
Journal:  Clin Cardiol       Date:  2020-09-24       Impact factor: 2.882

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.